Offer Letter, dated as of December 12, 2017, by and between Eiger BioPharmaceuticals, Inc. and David Apelian, M.D., Ph.D.Offer Letter • March 9th, 2018 • Eiger BioPharmaceuticals, Inc. • Biological products, (no disgnostic substances)
